Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
J Helminthol ; 93(4): 447-452, 2019 Jul.
Article de Anglais | MEDLINE | ID: mdl-29669605

RÉSUMÉ

Many important studies on resistance reversion, anthelmintic efficacy and, especially, new molecules with antiparasitic effects are performed in laboratories using gerbils (Meriones unguiculatus) as the experimental model. This study aimed to evaluate the use of corticosteroids (dexamethasone and methylprednisolone acetate) in gerbils experimentally infected with different doses of infective larvae (sheathed or exsheathed) of Haemonchus contortus. In the first experiment, 28 gerbils were divided into seven groups infected by 2-6 × 103 larvae, with or without immunosuppression using corticosteroids. In the second experiment, eight gerbils were divided into two groups infected by 2 × 103 sheathed or exsheathed larvae. For the third assay, seven immunosuppressed gerbils were infected with 2 × 103 sheathed larvae and were killed 15 days post infection (PI). The highest number of parasites was recovered from methylprednisolone-immunosuppressed animals. We observed red and white blood cell alterations and biochemical parameters in infected animals that had undergone immunosuppression with methylprednisolone. We highlight that in the first and second experiments a satisfactory number of worms was recovered using sheathed larvae and immunocompetent animals. When exsheathed larvae were used, the number of worms recovered was unsatisfactory. A considerable larval burden was recovered from immunosuppressed gerbils 15 days PI, and body weight did not influence establishment of larvae.


Sujet(s)
Gerbillinae/parasitologie , Infections à Haemonchus/parasitologie , Haemonchus/pathogénicité , Immunosuppresseurs/administration et posologie , Hormones corticosurrénaliennes/administration et posologie , Animaux , Modèles animaux de maladie humaine , Multirésistance aux médicaments , Femelle , Infections à Haemonchus/immunologie , Haemonchus/effets des médicaments et des substances chimiques , Immunosuppression thérapeutique/méthodes , Larve/effets des médicaments et des substances chimiques , Larve/pathogénicité , Mâle
2.
J Helminthol ; 90(3): 377-82, 2016 May.
Article de Anglais | MEDLINE | ID: mdl-26096177

RÉSUMÉ

Haemonchus contortus is one of the major gastrointestinal nematodes responsible for significant economic and production losses of sheep. Diseases caused by this species lack effective anthelmintic products, and the search for new compounds to replace synthetic anthelmintics has been extensive. The present investigation assesses the in vitro activity of the essential oil of melaleuca (Melaleuca alternifolia), both free (TTO) and nanostructured (nanoTTO), and terpinen-4-ol (terp-4-ol) on eggs and larvae of H. contortus. Tests of egg hatching (EHT) and inhibition of larval migration (LMIT) were used to assess the in vitro efficacy of TTO, nanoTTO and terp-4-ol. Using EHT, at a concentration of 3.5 mg/ml, 100% inhibition occurred using TTO and terp-4-ol, with LC50 values of 0.43 and 0.63 mg/ml, and LC90 values of 1.75 mg/ml and 3.12 mg/ml, respectively. NanoTTO had lower activity, with 82.6% inhibition at the same concentration. Using LMIT, TTO and nanoTTO had a similar activity with 88.0% and 84.8% inhibition, respectively, at a concentration of 56 mg/ml. Terp-4-ol had a greater effect on larvae, with 85.7% inhibition at a concentration of 56 mg/ml and 82.4% at 3.5 mg/ml, demonstrating high activity at the lowest concentration tested. Therefore, the results indicate that all substances tested showed ovicidal and larvicidal activity against H. contortus. TTO, terp-4-ol and, mainly, nanoTTO may be targeted in in vivo studies, besides being a promising line of research into the control and treatment of veterinary important helminths.


Sujet(s)
Anthelminthiques/pharmacologie , Haemonchus/effets des médicaments et des substances chimiques , Melaleuca/composition chimique , Huile essentielle/pharmacologie , Terpènes/pharmacologie , Zygote/effets des médicaments et des substances chimiques , Animaux , Anthelminthiques/isolement et purification , Dosage biologique , Haemonchus/croissance et développement , Larve/effets des médicaments et des substances chimiques , Locomotion/effets des médicaments et des substances chimiques , Huile essentielle/isolement et purification , Analyse de survie , Terpènes/isolement et purification
3.
Parasitology ; 142(3): 439-48, 2015 Mar.
Article de Anglais | MEDLINE | ID: mdl-25137643

RÉSUMÉ

This study aimed to evaluate in vitro and in vivo trypanocidal activity of free and nanoencapsulated curcumin against Trypanosoma evansi. In vitro efficacy of free curcumin (CURC) and curcumin-loaded in lipid-core nanocapsules (C-LNCs) was evaluated to verify their lethal effect on T. evansi. To perform the in vivo tests, T. evansi-infected animals were treated with CURC (10 and 100 mg kg(-1), intraperitoneally [i.p.]) and C-LNCs (10 mg kg(-1), i.p.) during 6 days, with the results showing that these treatments significantly attenuated the parasitaemia. Infected untreated rats showed protein peroxidation and an increase of nitrites/nitrates, whereas animals treated with curcumin showed a reduction on these variables. As a result, the activity of antioxidant enzymes (superoxide dismutase and catalase) differs between groups (P<0.05). Infected animals and treated with CURC exhibited a reduction in the levels of alanine aminotransferase and creatinine, when compared with the positive control group. The use of curcumin in vitro resulted in a better parasitaemia control, an antioxidant activity and a protective effect on liver and kidney functions of T. evansi-infected adult male Wistar rats.


Sujet(s)
Curcumine/pharmacologie , Trypanocides/pharmacologie , Trypanosoma/effets des médicaments et des substances chimiques , Trypanosomiase/traitement médicamenteux , Produits d'oxydation avancée des protéines/sang , Alanine transaminase/métabolisme , Phosphatase alcaline/métabolisme , Animaux , Aspartate aminotransferases/métabolisme , Catalase/sang , Créatinine/métabolisme , Curcumine/administration et posologie , Chiens , Concentration en ions d'hydrogène , Rein/parasitologie , Rein/anatomopathologie , Rein/physiopathologie , Foie/enzymologie , Foie/parasitologie , Foie/anatomopathologie , Mâle , Nanocapsules , Nitrates/sang , Nitrites/sang , Parasitémie/traitement médicamenteux , Parasitémie/parasitologie , Rats , Rat Wistar , Superoxide dismutase/sang , Trypanocides/administration et posologie , Trypanosomiase/anatomopathologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...